Luye Pharma Group Ltd.

OTCPK:LYPH.F Stock Report

Market Cap: US$1.0b

Luye Pharma Group Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Dian Bo Liu

Chief executive officer

CN¥4.2m

Total compensation

CEO salary percentage75.1%
CEO tenure21.5yrs
CEO ownershipn/a
Management average tenure13yrs
Board average tenure10.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Dian Bo Liu's remuneration changed compared to Luye Pharma Group's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

CN¥770m

Mar 31 2024n/an/a

CN¥652m

Dec 31 2023CN¥4mCN¥3m

CN¥533m

Sep 30 2023n/an/a

CN¥495m

Jun 30 2023n/an/a

CN¥458m

Mar 31 2023n/an/a

CN¥531m

Dec 31 2022CN¥3mCN¥3m

CN¥605m

Sep 30 2022n/an/a

CN¥190m

Jun 30 2022n/an/a

-CN¥224m

Mar 31 2022n/an/a

-CN¥179m

Dec 31 2021CN¥4mCN¥3m

-CN¥134m

Sep 30 2021n/an/a

CN¥210m

Jun 30 2021n/an/a

CN¥554m

Mar 31 2021n/an/a

CN¥630m

Dec 31 2020CN¥5mCN¥4m

CN¥707m

Sep 30 2020n/an/a

CN¥955m

Jun 30 2020n/an/a

CN¥1b

Mar 31 2020n/an/a

CN¥1b

Dec 31 2019CN¥4mCN¥3m

CN¥1b

Sep 30 2019n/an/a

CN¥1b

Jun 30 2019n/an/a

CN¥1b

Mar 31 2019n/an/a

CN¥1b

Dec 31 2018CN¥4mCN¥3m

CN¥1b

Compensation vs Market: Dian Bo's total compensation ($USD571.07K) is below average for companies of similar size in the US market ($USD3.22M).

Compensation vs Earnings: Dian Bo's compensation has increased by more than 20% in the past year.

CEO

Dian Bo Liu (58 yo)

21.5yrs

Tenure

CN¥4,180,000

Compensation

Mr. Dian Bo Liu is a Co-Founder of Luye Pharma Group Ltd. in 1994 and serves as its Head of Corporate Directions & Strategies and has been its Chief Executive Officer since July 2003. Mr. Liu is responsibl...

Leadership Team

NamePositionTenureCompensationOwnership
Dian Bo Liu
Co-Founder21.5yrsCN¥4.18mno data
Rong Bing Yang
Co-Founder & Vice Executive Chairman21.5yrsCN¥3.09mno data
Hui Xian Yuan
Co-Founder & Executive Directorno dataCN¥1.46mno data
Yuan Yuan Zhu
Executive Directorno dataCN¥1.50mno data
Yuan Chong Liu
Chief Financial Officer13yrsno datano data
Mei Yi Lee
Company Secretary4.1yrsno datano data

13.0yrs

Average Tenure

58yo

Average Age

Experienced Management: LYPH.F's management team is seasoned and experienced (13 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Dian Bo Liu
Co-Founder21.5yrsCN¥4.18mno data
Rong Bing Yang
Co-Founder & Vice Executive Chairman21.5yrsCN¥3.09mno data
Hui Xian Yuan
Co-Founder & Executive Director21.5yrsCN¥1.46mno data
Yuan Yuan Zhu
Executive Director10.8yrsCN¥1.50mno data
Yuk Lam Lo
Independent Non-Executive Director10.6yrsCN¥269.00kno data
Man Kit Leung
Independent Non-Executive Director10.6yrsCN¥322.00kno data
Rui Lin Song
Non-Executive Director7.8yrsCN¥269.00kno data
Sze Chung Choy
Independent Non-Executive Director10.6yrsCN¥269.00kno data
Huaqiao Zhang
Independent Non-Executive Director10.6yrsCN¥269.00kno data
Dong Lyu
Non-Executive Director1.1yrsno datano data
Lian Xia
Independent Non-Executive Director1.7yrsCN¥162.00kno data

10.6yrs

Average Tenure

61yo

Average Age

Experienced Board: LYPH.F's board of directors are seasoned and experienced ( 10.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/04 06:17
End of Day Share Price 2024/11/18 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Luye Pharma Group Ltd. is covered by 21 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ling ZhangBNP Paribas Securities (Asia)
Jessica LiBofA Global Research
Lok Kwan ChiuCCB International Securities Limited